GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

divozilimab   Click here for help

GtoPdb Ligand ID: 13087

Synonyms: BCD 132 | BCD-132 | Ivlizi®
Approved drug Immunopharmacology Ligand
divozilimab is an approved drug (Russia (2023))
Compound class: Antibody
Comment: Divozilimab (BCD 132) is an anti-CD20 monoclonal antibody that was developed by Biocad.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. Russia MinzDRAV (2023)
International Nonproprietary Names Click here for help
INN number INN
11336 divozilimab
Synonyms Click here for help
BCD 132 | BCD-132 | Ivlizi®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1060
Other databases
GtoPdb PubChem SID 491299869
Search PubMed clinical trials divozilimab
Search PubMed titles divozilimab
Search PubMed titles/abstracts divozilimab